Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2)
Clinical trial NCT00518687 · TERMINATED
Trial details
- NCT number
- NCT00518687
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2011-08-01
- Enrollment
- 8031
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.